|
BCRT101
|
OriGene Technologies
|
TissueScan, Breast Cancer cDNA Array I
|
|
|
|
|
BCRT102
|
OriGene Technologies
|
TissueScan, Breast Cancer cDNA Array II
|
|
|
|
|
BCRT103
|
OriGene Technologies
|
TissueScan, Breast Cancer cDNA Array III
|
|
|
|
|
BCRT104
|
OriGene Technologies
|
TissueScan, Breast Cancer cDNA Array IV
|
|
|
|
|
BCRT301
|
OriGene Technologies
|
TissueScan, Breast Cancer cDNA Array I
|
|
|
|
|
BCRT302
|
OriGene Technologies
|
TissueScan, Breast Cancer cDNA Array II
|
|
|
|
|
BCRT303
|
OriGene Technologies
|
TissueScan, Breast Cancer cDNA Array III
|
|
|
|
|
BCRT304
|
OriGene Technologies
|
TissueScan, Breast Cancer cDNA Array IV
|
|
|
|
|
BCRT501
|
OriGene Technologies
|
TissueScan, Breast Cancer cDNA Array I
|
|
|
|
|
BCRT502
|
OriGene Technologies
|
TissueScan, Breast Cancer cDNA Array II
|
|
|
|
|
BCRT503
|
OriGene Technologies
|
TissueScan, Breast Cancer cDNA Array III
|
|
|
|
|
BCRT504
|
OriGene Technologies
|
TissueScan, Breast Cancer cDNA Array IV
|
|
|
|
|
BLRT101
|
OriGene Technologies
|
TissueScan, Bladder Cancer cDNA Array I
|
|
|
|
|
BLRT301
|
OriGene Technologies
|
TissueScan, Bladder Cancer cDNA Array I
|
|
|
|
|
BLRT501
|
OriGene Technologies
|
TissueScan, Bladder Cancer cDNA Array I
|
|
|
|
|
CCRT101
|
OriGene Technologies
|
TissueScan, Crohn's/Colitis cDNA Array I
|
|
|
|
|
CCRT102
|
OriGene Technologies
|
TissueScan, Crohn's/Colitis cDNA Array II
|
|
|
|
|
CCRT301
|
OriGene Technologies
|
TissueScan, Crohn's/Colitis cDNA Array I
|
|
|
|
|
CCRT302
|
OriGene Technologies
|
TissueScan, Crohn's/Colitis cDNA Array II
|
|
|
|
|
CCRT501
|
OriGene Technologies
|
TissueScan, Crohn's/Colitis cDNA Array I
|
|
|
|
|
CCRT502
|
OriGene Technologies
|
TissueScan, Crohn's/Colitis cDNA Array II
|
|
|
|
|
CD563065
|
OriGene Technologies
|
Tissue Genomic DNA, Kidney
|
|
|
|
|
CD563066
|
OriGene Technologies
|
Tissue Genomic DNA, Prostate
|
|
|
|
|
CD563067
|
OriGene Technologies
|
Tissue Genomic DNA, Ovary: left
|
|
|
|
|
CD563069
|
OriGene Technologies
|
Tissue Genomic DNA, Colon: right
|
|
|
|
